KA‐104, a new multitargeted anticonvulsant with potent antinociceptive activity in preclinical models-Reference-Cited by-同舟云学术

KA‐104, a new multitargeted anticonvulsant with potent antinociceptive activity in preclinical models

Published:2020-09-14 Issue:10 Volume:61 Page:2119-2128
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Kamiński Krzysztof¹^ORCID,Mogilski Szczepan²,Abram Michał¹,Rapacz Anna²,Latacz Gniewomir³,Szulczyk Bartłomiej⁴,Walczak Maria⁵⁶,Kuś Kamil⁵⁶,Matyjaszczyk Karolina⁵⁶,Kamiński Rafał M.¹

Affiliation:

1. Department of Medicinal Chemistry Faculty of Pharmacy Jagiellonian University Medical College Cracow Poland

2. Department of Pharmacodynamics Faculty of Pharmacy Jagiellonian University Medical College Cracow Poland

3. Department of Technology and Biotechnology of Drugs Faculty of Pharmacy Jagiellonian University Medical College Cracow Poland

4. Department of Pharmacodynamics Center for Preclinical Research and Technology Medical University of Warsaw Warsaw Poland

5. Department of Toxicology Faculty of Pharmacy Jagiellonian University Medical College Cracow Poland

6. Jagiellonian Center for Experimental Therapeutics Jagiellonian University Cracow Poland

Funder

Narodowym Centrum Nauki

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.16669

Reference38 articles.

1. Neuropathic pain

2. Current treatments of epilepsy

3. Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers

4. Current and emerging targets to treat neuropathic pain;Butera JA;J Med Chem,2007

5. Common psychiatric comorbidities in epilepsy: How big of a problem is it?

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Novel Alaninamide Derivatives with Anticonvulsant Activity and Favorable Safety Profiles in Animal Models;International Journal of Molecular Sciences;2024-09-12

2. TRPV1 channel in the pathophysiology of epilepsy and its potential as a molecular target for the development of new antiseizure drug candidates;Progress in Neurobiology;2024-09

3. Discovery and Profiling of New Multimodal Phenylglycinamide Derivatives as Potent Antiseizure and Antinociceptive Drug Candidates;ACS Chemical Neuroscience;2024-08-21

4. Novel Alaninamide Derivatives with Drug-like Potential for Development as Antiseizure and Antinociceptive Therapies─In Vitro and In Vivo Characterization;ACS Chemical Neuroscience;2024-05-14

5. Mechanochemical synthesis and anticonvulsant activity of 3-aminopyrrolidine-2,5-dione derivatives;Biomedicine & Pharmacotherapy;2023-12